Welcome to Chinese Journal of Clinical Pharmacology and Therapeutics,Today is Chinese

Chinese Journal of Clinical Pharmacology and Therapeutics ›› 2026, Vol. 31 ›› Issue (8): 1101-1111.doi: 10.12092/j.issn.1009-2501.2026.08.011

Previous Articles    

An introduction to statistical analysis methods for clinical trials using covariate-adaptive randomization

Yuxuan YANG1(), Siyu ZHU1, Minggang YIN1, Jianhong PAN2,*(), Chongyang DUAN1,*()   

  1. 1. State Key Laboratory of Multi-organ Injury Prevention and Treatment, Southern Medical University, Guangzhou 510515, Guangdong, China
    2. Center for Drug Evaluation, National Medical Products Administration, Beijing 100022, China
  • Received:2025-04-21 Revised:2025-06-16 Online:2026-08-26 Published:2026-09-09
  • Contact: Jianhong PAN,Chongyang DUAN E-mail:yuxuanyang402@qq.com;panjh@cde.org.cn;donyduang@126.com

Abstract:

Covariate-adaptive randomization is increasingly used in drug clinical trials because it helps balance prognostic factors that may affect trial outcomes between treatment groups. When performing statistical analyses of such trials, researchers usually consider it necessary to adjust for the covariates used in randomization. Therefore, regression models and stratified analyses are commonly employed for statistical inferences. However, no systematic studies have been conducted to discuss the rationality and applicability of these methods. To address this gap, the present study reviews the existing literature, examines the adaptability of traditional statistical inference methods for trials using covariate-adaptive randomization, and introduces the "robust" statistical inference methods proposed in recent years. In addition, to facilitate practical implementation by clinical researchers, example code is provided to demonstrate the application of these methods.

Key words: adaptive-randomization, stratified analysis, covariate-adjusted, robust analysis method, software operation

CLC Number: